Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FV438
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $72,335
Award facts
- Contract value 100% obligated
- $72,334.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $72,334.85 to AmerisourceBergen Drug Corp for the supply of COSENTYX (secukinumab) UNOREADY 300 MG PEN 2ML on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving federal healthcare programs.
This delivery order is executed under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. COSENTYX is a specialty biologic medication used primarily in the treatment of autoimmune and inflammatory conditions, reflecting the Defense Logistics Agency's mission to supply critical pharmaceutical commodities for military healthcare systems worldwide. The contract demonstrates AmerisourceBergen's established capability to fulfill federal medical supply requirements through competitive procurement and its role as a key vendor supporting defense and military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FV438?
SPE2DR26FV438 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 12, 2026.
How much is contract SPE2DR26FV438 worth?
The government has obligated $72,335 on SPE2DR26FV438.
Is contract SPE2DR26FV438 an order under another contract?
Yes. SPE2DR26FV438 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV438 competed?
The extent of competition for SPE2DR26FV438 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award